Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Ariel Miller(Technion – Israel Institute of Technology), Howard L. Weiner(Baylor College of Medicine)
Cited by 728
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
|Nature Neuroscience|2019|528
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
|The Lancet|1999|500
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet|2016|449
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
|Journal of Clinical Investigation|2003|301